Literature DB >> 17206722

Clinical features and natural history of ulcerative colitis in Korea.

Sang Hyoung Park1, Young Min Kim, Suk-Kyun Yang, Sai-Hui Kim, Jeong-Sik Byeon, Seung-Jae Myung, Yun Kyung Cho, Chang-Sik Yu, Kwi-Sook Choi, Jun-Won Chung, Benjamin Kim, Kee Don Choi, Jin-Ho Kim.   

Abstract

BACKGROUND: The clinical characteristics of ulcerative colitis (UC) in Asian populations have not been well characterized. We therefore investigated the clinical features and natural history of UC in Korea.
METHODS: We retrospectively analyzed 304 Korean patients with UC first diagnosed at the Asan Medical Center between June 1989 and August 2005.
RESULTS: The male-to-female ratio of the patients was 0.94:1, and their median age at diagnosis was 40.0 years (range, 12-72 years). At diagnosis, proctitis was noted in 134 patients (44.1%), left-sided colitis in 69 patients (22.7%), and extensive colitis in 101 patients (33.2%). Disease activity at diagnosis was mild in 149 patients (49.0%), moderate in 125 patients (41.1%), and severe in 26 patients (8.6%). In addition, 4 asymptomatic patients (1.3%) were detected as a result of a screening colonoscopy. Clinical remission after the first attack was documented in 97.4% of patients. The cumulative relapse rate after 1, 5, and 10 years was 30.2%, 72.0%, and 88.4%, respectively. The cumulative risk of proximal extension in patients with proctitis or left-sided colitis was 33.0% after 5 years and 44.5% after 10 years. The cumulative probability of colectomy was 2.0% after 1 year, 2.8% after 3 years, and 3.3% after 5 to 15 years. The cumulative survival rate after 1, 5, and 10 years was 100%, 99.4%, and 97.4%, respectively.
CONCLUSIONS: The clinical features of Korean UC patients at diagnosis are similar to those of Westerners. However, UC in Koreans may have a milder course than in Westerners, as indicated by the lower rate of colectomy among Koreans.

Entities:  

Mesh:

Year:  2007        PMID: 17206722     DOI: 10.1002/ibd.20015

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  34 in total

1.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

2.  The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis.

Authors:  Jin Ha Lee; Jae Hee Cheon; Eun Soo Kim; Moon Jae Chung; Wonseok Kang; Duk Hwan Kim; You Jung Ha; Jae Jun Park; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2009-06-09       Impact factor: 3.199

Review 3.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

4.  Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis.

Authors:  Han Ho Jeon; Hyun Jung Lee; Hui Won Jang; Jin Young Yoon; Yoon Suk Jung; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

5.  Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt.

Authors:  Serag Esmat; Mohamed El Nady; Mohamed Elfekki; Yehia Elsherif; Mazen Naga
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

6.  Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.

Authors:  Yoon Suk Jung; Minkyung Han; Won Ho Kim; Sohee Park; Jae Hee Cheon
Journal:  Dig Dis Sci       Date:  2017-06-07       Impact factor: 3.199

7.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

9.  Survey of inflammatory bowel diseases in India.

Authors:  Govind K Makharia; Balakrishnan S Ramakrishna; Philip Abraham; Gourdas Choudhuri; Sri Prakash Misra; Vineet Ahuja; Shobna J Bhatia; Deepak K Bhasin; Sunil Dadhich; Gopal K Dhali; Devendra C Desai; Uday C Ghoshal; B D Goswami; Sanjeev K Issar; Ajay K Jain; Venkataraman Jayanthi; Goundappa Loganathan; C Ganesh Pai; Amarender S Puri; Surinder S Rana; Gautam Ray; Shivaram P Singh; Ajit Sood
Journal:  Indian J Gastroenterol       Date:  2012-10-17

10.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.